A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,551 shares of ORIC stock, worth $22,295. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,551
Previous 2,013 26.73%
Holding current value
$22,295
Previous $14,000 85.71%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$7.52 - $11.9 $4,045 - $6,402
538 Added 26.73%
2,551 $26,000
Q2 2024

Jul 30, 2024

BUY
$6.63 - $12.93 $13,346 - $26,028
2,013 New
2,013 $14,000
Q4 2023

Jan 24, 2024

BUY
$5.41 - $9.43 $7,368 - $12,843
1,362 Added 6.59%
22,043 $202,000
Q2 2023

Aug 10, 2023

BUY
$4.95 - $8.4 $102,370 - $173,720
20,681 New
20,681 $160,000

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $346M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.